Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (Q34558842)

3 August 2017

1 reference

MDMA

0 references

title

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

1 reference

Parrott AC

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Pharmacology, Biochemistry and Behavior

3 August 2017

published in

1 reference

3 August 2017

volume

71

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

837-844

1 reference

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Serotonin syndrome: history and risk

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

The serotonin syndrome and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

A method of conducting therapeutic sessions with MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Long term psychiatric and cognitive effects of MDMA use.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Drug use among college undergraduates: current use and 10-year trends

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Ecstasy (MDMA): a review of its possible persistent psychological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

A review of the role of serotonin receptors in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Does cigarette smoking cause stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Cognitive performance amongst recreational users of "ecstasy".

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Is the use of ecstasy and hallucinogens increasing? Results from a community study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

Alcohol and drug use in UK university students.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900711-0

7 January 2021

10.1016/S0091-3057(01)00711-0

Identifiers

DOI

1 reference

3 August 2017

1 reference